Name and surname:
|
Mgr. Andrea Hornáková, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
scientific researcher | Jessenius faculty of medicine in Martin Comenius University Bratislava | 2014-2021 |
scientific researcher | Jessenius faculty of medicine in Martin Comenius University Bratislava | 2022-current |
Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova (Hornakova) A, Kajo K, Lasabova Z, Plank L, Danko J. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep. 2013 Dec;30(6):2878-86. doi: 10.3892/or.2013.2752.
Holubeková V, Mendelová (Hornáková) A, Grendár M, Meršaková S, Kapustová I, Jašek K, Vaňochová A, Danko J, Lasabová Z. Methylation pattern of CDH1 promoter and its association with CDH1 gene expression in cytological cervical specimens. Oncol Lett. 2016 Oct;12(4):2613-2621. doi: 10.3892/ol.2016.5004.
Mendelova (Hornakova) A, Holubekova V, Grendar M, Zubor P, Svecova I, Loderer D, Snahnicanova Z, Biringer K, Danko J, Lasabova Z. Association between 3'UTR polymorphisms in genes ACVR2A, AGTR1 and RGS2 and preeclampsia. Gen Physiol Biophys. 2018 Mar;37(2):185-192. doi: 10.4149/gpb_2017028.
Hornakova A, Kolkova Z, Holubekova V, Loderer D, Lasabova Z, Biringer K, Halasova E. Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of Preeclampsia. Genet Test Mol Biomarkers. 2020 Jun;24(6):321-327. doi: 10.1089/gtmb.2019.0264.
Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, Loderer D, Zigo I, Biringer K, Hornakova A. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics (Basel). 2021 Mar 8;11(3):476. doi: 10.3390/diagnostics11030476.
Hornakova A, Kolkova Z, Holubekova V, Loderer D, Lasabova Z, Biringer K, Halasova E. Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of Preeclampsia. Genet Test Mol Biomarkers. 2020 Jun;24(6):321-327. doi: 10.1089/gtmb.2019.0264.
Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, Loderer D, Zigo I, Biringer K, Hornakova A. Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics (Basel). 2021 Mar 8;11(3):476. doi: 10.3390/diagnostics11030476.
Kudelova E, Smolar M, Holubekova V, Hornakova A, Dvorska D, Lucansky V, Koklesova L, Kudela E, Kubatka P. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. Int J Mol Sci. 2022 Nov 29;23(23):14937. doi: 10.3390/ijms232314937.
Lucansky V, Samec M, Burjanivova T, Lukacova E, Kolkova Z, Holubekova V, Turyova E, Hornakova A, Zaborsky T, Podlesniy P, Reizigova L, Dankova Z, Novakova E, Pecova R, Calkovska A, Halasova E. Comparison of the methods for isolation and detection of SARS-CoV-2 RNA in municipal wastewater. Front Public Health. 2023 Mar 7;11:1116636. doi: 10.3389/fpubh.2023.1116636.
Loderer D, Hornáková A, Tobiášová K, Lešková K, Halašová E, Danková Z, Biringer K, Kúdela E, Rokos T, Dzian A, Miklušica J, Mikolajčík P, Smolár M, Plank L, Grendár M. Comparison of next‑generation sequencing quality metrics and concordance in the detection of cancer‑specific molecular alterations between formalin‑fixed paraffin‑embedded and fresh‑frozen samples in comprehensive genomic profiling with the Illumina® TruSight Oncology 500 assay. Exp Ther Med. 2025 Feb 4;29(4):64. doi: 10.3892/etm.2025.12814.
APVV-17-0037: Development of novel in vitro models for amyotrophic lateral sclerosis and testing the safety of human induced pluripotent stem cell-derived neural precursors.
VEGA 1/0272/19: Application of circulating miRNA as a potential biomarkers of pregnancy complications.
ITMS2014+: 313011V446 „Integrative strategy in the development of personalized medicine for selected malignancies and its impact on quality of life.“
09I03-03-V04-00228: Epigenetic changes in the developmentof cervical cancer.
APVV-23-0428: The role of the vaginal microbiome and the immune system in the process of HPV- induced cervical carcinogenesis.